Borenius advised Aiforia on a directed share issue

We advised Aiforia Technologies Plc in connection with a directed share issue of approximately EUR 10 million through an accelerated book building procedure.

Aiforia successfully completed the share issue on 22 May 2024. The proceeds from the share issue will be used to support Aiforia’s growth strategy by enhancing its research & development function and accelerating the regulatory approval process in the US for its AI-assisted software solutions. The placing to domestic and international institutional and other qualified investors was carried out based on offers received in an accelerated book building procedure.

Aiforia is a trusted provider of deep learning artificial intelligence (AI) solutions for pathology. Aiforia delivers software solutions that elevate diagnostic capabilities in image analysis, enabling remarkable medical discoveries now and in the future. With thousands of AI models already developed on the Aiforia platform for research use and several diagnostic solutions deployed, Aiforia is already significantly impacting pathology and healthcare.